NEW YORK (AP) – Baltimore outfielder Jay Gibbons met with two officials from the baseball commissioner’s office to discuss a report he received performance-enhancing steroids and human growth hormone after both substances were banned by baseball.
Gibbons met Monday with Rob Manfred, baseball’s executive vice president for labor relations, and Jon Coyles, the sport’s director of drug testing. Michael Weiner, general counsel of the players’ association, also attended the session.
There was no indication whether there would be any follow-up, a person familiar with the meeting said, speaking on condition of anonymity because no details were announced.
The meeting was first reported Tuesday by The Sun in Baltimore on its Web site.
“I met with Major League Baseball representatives (yesterday) and was happy to answer all of their questions,” Gibbons was quoted as saying by The Sun.
Gibbons got six shipments of Genotropin (a brand name for synthetic human growth hormone), two shipments of testosterone and two shipments of human chorionic gonadotropin (HCG) between October 2003 and July 2005, SI.com said on Sept. 9, citing a source in Florida with knowledge of a Signature Pharmacy client list.
The substances were obtained through South Beach Rejuvenation Center/Modern Therapy, a Miami Beach clinic, and sent through Signature, SI.com said. The pharmacy is under investigation for illegally distributing prescription medications.
If Gibbons were found to have used HGH in 2005, he could be subject to a 10-day suspension, the penalty for a first offense that year.
St. Louis outfielder Rick Ankiel met with baseball lawyers Sept. 11 following a report by the New York Daily News that he received eight shipments of prescription HGH in 2004, before it was banned by baseball.
Baseball officials have not yet met with Toronto third baseman Troy Glaus, who received multiple shipments of nandrolone and testosterone between September 2003 and May 2004, SI.com reported. Glaus had season-ending foot surgery Monday.
Add A Comment